The current VVOS market cap is 3.21M. The company's latest EPS is USD -11.3451 and P/E is -0.23.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 4.25M | 3.95M | 3.86M | 3.4M | 3.3M |
Operating Income | -5.41M | -6.06M | -5.01M | -4.52M | -3.49M |
Net Income | -5.43M | -6.09M | -1.7M | -5.53M | -2.09M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 11.39M | 13.07M | 16.89M | 16.02M | 13.8M |
Operating Income | -10.58M | -12.04M | -19.47M | -25.03M | -17.3M |
Net Income | -11.75M | -6.13M | -20.29M | -23.85M | -13.58M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 18.4M | 13.72M | 17.1M | 13.75M | 10.32M |
Total Liabilities | 8.55M | 8.92M | 10.11M | 11.64M | 10.27M |
Total Equity | 9.86M | 4.8M | 6.99M | 2.11M | 46k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 7.55M | 25.33M | 33.69M | 13.72M | 10.73M |
Total Liabilities | 9.18M | 8.41M | 8.15M | 8.92M | 10.32M |
Total Equity | -2.94M | 16.92M | 25.54M | 4.8M | 411k |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -16.59M | -19.59M | -3.54M | -6.4M | -9.2M |
Investing | -724k | -924k | -289k | -534k | -688k |
Financing | N/A | N/A | 7.36M | 7.36M | 7.36M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -5.34M | -5.68M | -15.74M | -19.59M | -11.95M |
Investing | 86k | -120k | -2.61M | -924k | -853k |
Financing | 4.47M | 23.54M | 24.17M | N/A | 10.92M |
Market Cap | 3.21M |
Price to Earnings Ratio | -0.23 |
Price to Sales Ratio | 0.23 |
Price to Cash Ratio | 1.93 |
Price to Book Ratio | 7.72 |
Dividend Yield | - |
Shares Outstanding | 1.2M |
Average Volume (1 week) | 98.37k |
Average Volume (1 Month) | 411.53k |
52 Week Change | -71.64% |
52 Week High | 48.79 |
52 Week Low | 2.40 |
Spread (Intraday) | 0.04 (1.48%) |
Company Name | Vivos Therapeutics Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://vivos.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.